| Literature DB >> 30686041 |
Craig T January, L Samuel Wann, Hugh Calkins1, Lin Y Chen1, Joaquin E Cigarroa1, Joseph C Cleveland1, Patrick T Ellinor1, Michael D Ezekowitz1, Michael E Field1, Karen L Furie1, Paul A Heidenreich1, Katherine T Murray1, Julie B Shea1, Cynthia M Tracy1, Clyde W Yancy1.
Abstract
Entities:
Keywords: AHA Scientific Statements; acute coronary syndrome; anticoagulants; anticoagulation agents; antiplatelet agents; apixaban; atrial fibrillation; atrial flutter; cardioversion; coronary artery disease; coronary heart disease; dabigatran; edoxaban; focused update; hypertension; idarucizumab; myocardial infarction; obesity; percutaneous coronary intervention; risk factors; rivaroxaban; sleep apnea; stents; stroke; thromboembolism; warfarin
Mesh:
Year: 2019 PMID: 30686041 DOI: 10.1161/CIR.0000000000000665
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690